Chronic Graft Versus Host Disease Clinical Trials in Seattle, Washington
10 recruitingSeattle, Washington
Showing 1–10 of 10 trials
Recruiting
Phase 2
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Lung DiseasesBronchiolitis Obliterans SyndromeChronic Graft Versus Host Disease+1 more
Dana-Farber Cancer Institute45 enrolled6 locationsNCT05922761
Recruiting
Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+4 more
Janssen Research & Development, LLC700 enrolled175 locationsNCT01804686
Recruiting
Phase 2
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
Chronic Graft Versus Host Disease
Fred Hutchinson Cancer Center82 enrolled5 locationsNCT05996627
Recruiting
Phase 2
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
Chronic Graft Versus Host Disease
Sanofi37 enrolled33 locationsNCT07116031
Recruiting
Phase 2
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
Chronic Graft Versus Host Disease
Incyte Corporation60 enrolled41 locationsNCT07124078
Recruiting
Not Applicable
Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease
Acute Graft Versus Host DiseaseHematopoietic and Lymphatic System NeoplasmChronic Graft Versus Host Disease
Fred Hutchinson Cancer Center45 enrolled1 locationNCT07535008
Recruiting
Phase 2
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft Versus Host Disease
Syndax Pharmaceuticals296 enrolled121 locationsNCT04710576
Recruiting
Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study
Chronic Graft Versus Host Disease
Fred Hutchinson Cancer Center300 enrolled10 locationsNCT04431479
Recruiting
Phase 2
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
Chronic Graft Versus Host Disease
Fred Hutchinson Cancer Center50 enrolled3 locationsNCT07011810
Recruiting
Phase 2
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
Chronic Graft Versus Host Disease
Incyte Corporation120 enrolled70 locationsNCT06388564